Galapagos reported EUR38.52M in Stock for its fiscal quarter ending in March of 2025.


Stock Change Date
argenx SE USD 340.62M 66.61M Jun/2025
AstraZeneca USD 6.47B 583M Jun/2025
Biogen USD 2.27B 400K Jun/2025
Genmab DKK 13M 1000K Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
GRIFOLS EUR 3.35B 213.23M Jun/2025
Hikma Pharmaceutical USD 986M 50M Dec/2024
Incyte USD 83.42M 19.45M Jun/2025
Merck EUR 4.47B 45M Jun/2025
Neurocrine Biosciences USD 56.9M 2.2M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Sanofi EUR 9.62B 12.23B Jun/2025
UCB 1.31B 173M Dec/2024
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025